-
Lupin Atlantis Holdings S.A. v. Ranbaxy Laboratories Limited et al DC
- 1:11-cv-03894
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 06/08/2011
- Closed: 12/12/2011
- Latest Docket Entry: 12/28/2012
- PACER
- Docket updated daily
1
Plaintiff
4
Defendants
1
Accused
Product
1
Patent-in-Suit
496
Days in
Litigation
-
Lupin Atlantis Holdings S.A. v. Ranbaxy Laboratories Limited et al DC
- 1:11-cv-03894
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 06/08/2011
- Closed: 12/12/2011
- Latest Docket Entry: 12/28/2012
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Apotex Corporation
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic ANTARA | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
Apotex Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic ANTARA | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic ANTARA | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic ANTARA | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
